Klin Farmakol Farm. 2011;25(3):126-130

Anticholinergic effects of drugs in elderly patients

Agáta Mačugová1, Magdaléna Kuželová2, Lenka Kostková1, Veronika Drobná1, Ján Luha3, Andrej Dukát4, Ján Murín5, Kamil Stratený1, Martin Wawruch1
1 Ústav farmakológie a klinickej farmakológie, Lekárska fakulta, Univerzita Komenského, Bratislava
2 Katedra farmakológie a toxikológie, Farmaceutická fakulta UK, Bratislava
3 Ústav lekárskej biológie, genetiky a klinickej genetiky, Lekárska fakulta, Univerzita Komenského, Bratislava
4 II. interná klinika, Lekárska fakulta, Univerzita Komenského, Bratislava
5 I. interná klinika, Lekárska fakulta, Univerzita Komenského, Bratislava

Elderly patients represent a special group of population regarding the occurrence of adverse drug reactions. The adverse drug reactions

often remain unrecognised due to their non-characteristic symptoms and polymorbidity of elderly patients. In case of manifestation of

adverse drug reaction sometimes additional medication is added instead of adjustment of the dose of drug or its withdrawal. Anticholinergic

effects of medications represent a typical example of such often unrecognised adverse drug reactions. These drugs may cause

peripheral adverse drug reactions, e.g. dry mouth, constipation, urinary retention, tachycardia, mydriasis, inability to accommodate,

increased intraocular pressure or decreased secretion of sweat glands. Anticholinergic effects of medications on the central nervous

system may be a cause of sedation, worsening of cognitive functions or delirium. Many drugs show anticholinergic properties, however

in most cases these effects are not responsible for the mechanism of therapeutic action (e.g. amitriptyline, clozapine). The appropriate

identification of drugs with anticholinergic effects represents the basic condition for the reduction of anticholinergic burden of elderly

patients. There are several laboratory in vitro methods. The most important limitation of these methods is a complicated interpretation

of their results in clinical practice. The lists of drugs with anticholinergic properties represent a tool easily applicable in daily clinical

practice. The creation of such lists is based on the consensus of experts who take into consideration the literature data on individual

drugs as well as their own clinical experience. The aim of our article was to introduce the topic of anticholinergic effects of drugs. The

stress is put on the consequences of their manifestation as adverse drug reactions. The opportunities of identification of medications

with anticholinergic properties are described.

Keywords: anticholinergic, adverse effects, drugs, lists, withdrawal syndrome

Published: December 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Mačugová A, Kuželová M, Kostková L, Drobná V, Luha J, Dukát A, et al.. Anticholinergic effects of drugs in elderly patients. Klin Farmakol Farm. 2011;25(3):126-130.
Download citation

References

  1. Beijer HJ, de Blaey CJ. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm Sci 2002; 24: 46-54. Go to original source...
  2. Field TS, Gurwitz JH, Harrold LR, et al. Risk factors for adverse drug events among older adults in the ambulatory setting. J Am Geriatr Soc 2004; 52: 1349-1354. Go to original source... Go to PubMed...
  3. van der Hooft CS, Sturkenboom MCJ, van Grootheest K, et al. Adverse drug reaction-related hospitalisations: A nationwide study in the Netherlands. Drug Saf 2006; 29: 161-168. Go to original source... Go to PubMed...
  4. Wawruch M, Zikavska M, Wsolova L, et al. Adverse drug reactions related to hospital admission in Slovak elderly patients. Arch Gerontol Geriatr 2009; 48: 186-190. Go to original source... Go to PubMed...
  5. Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults. Arch Intern Med 2003; 163: 2716-2724. Go to original source... Go to PubMed...
  6. McLeod PJ, Huang AR, Tamblyn RM, et al. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ 1997; 156: 385-391. Go to PubMed...
  7. Laroche ML, Charmes JP, Merle L. Potentially inappropriate medications in the elderly. Eur J Clin Pharmacol 2007; 63: 725-731. Go to original source... Go to PubMed...
  8. Kalvach Z, Zadák Z, Jirák R, Zavázalová H, Holmerová I, Weber P. Geriatrické syndromy a geriatrický pacient. Praha: Grada, 2008: 336.
  9. Midlov P, Eriksson T, Kragh A. Drug-related problems in the elderly. London: Springer, 2009: 135. Go to original source...
  10. Weber P, Kriška M, Meluzínová H, Dítětová K, Wawruch M. Polyfarmakoterapie v klinické gerontologii. Čas Lék Čes 2004; 143: 547-551.
  11. Bartus RT, Dean RL 3rd, Beer B, Lippa AS. The cholinergic hypothesis of geriatric memory dysfunction. Science 1982; 217: 408-414. Go to original source... Go to PubMed...
  12. Tune LE. Anticholinergic effects of medication in elderly patients. J Clin Psychiatry 2001; 62(Suppl 21): 11-14.
  13. Bressler R, Bahl JJ. Principles of drug therapy for the elderly patient. Mayo Clin Proc 2003; 78: 1564-1577. Go to original source... Go to PubMed...
  14. Catterson ML, Preskorn SH, Martin RL. Pharmacodynamic and pharmacokinetic considerations in geriatric psychopharmacology. Psychiatr Clin North Am 1997; 20: 205-218. Go to original source... Go to PubMed...
  15. Lechevallier-Michel N, Molimard M, Dartigues JF, Fabrigoule C, Fourrier-Réglat A. Drugs with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID Study. Br J Clin Pharmacol 2005; 59: 143-151. Go to original source... Go to PubMed...
  16. Ness J, Hoth A, Barnett MJ, Shorr RI, Kaboli PJ. Anticholinergic medications in community-dwelling older veterans: prevalence of anticholinergic symptoms, symptom burden, and adverse drug events. Am J Geriatr Pharmacother 2006; 4: 42-51. Go to original source... Go to PubMed...
  17. Mintzer J, Burns A. Anticholinergic side-effects of drugs in elderly people. J R Soc Med 2000; 93 :457-462. Go to original source... Go to PubMed...
  18. Triantafyllou K, Vlachogiannakos J, Ladas SD. Gastrointestinal and liver side effects of drugs in elderly patients. Best Pract Res Clin Gastroenterol 2010; 24: 203-215. Go to original source... Go to PubMed...
  19. Verhamme KM, Sturkenboom MC, Stricker BH, Bosch R. Drug-induced urinary retention: incidence, management and prevention. Drug Saf 2008; 31: 373-388. Go to original source... Go to PubMed...
  20. Barnes BJ, Hollands JM. Drug-induced arrhythmias. Crit Care Med 2010; 38(Suppl 6): S188-197. Go to original source... Go to PubMed...
  21. Feinberg M. The problems of anticholinergic adverse effects in older patients. Drugs Aging 1993; 3: 335-348. Go to original source... Go to PubMed...
  22. Li J, Tripathi RC, Tripathi BJ. Drug-induced ocular disorders. Drug Saf 2008; 31: 127-141. Go to original source... Go to PubMed...
  23. Cheshire WP, Fealey RD. Drug-induced hyperhidrosis and hypohidrosis: incidence, prevention and management. Drug Saf 2008; 31: 109-126. Go to original source... Go to PubMed...
  24. Cancelli I, Beltrame M, Gigli GL, Valente M. Drugs with anticholinergic properties: cognitive and neuropsychiatric sideeffects in elderly patients. Neurol Sci 2009; 30: 87-92. Go to original source... Go to PubMed...
  25. Francis J, Martin D, Kapoor WN. A prospective study of delirium in hospitalized elderly. JAMA 1990; 263: 1097-1101. Go to original source...
  26. Tune LE, Bylsma FW. Benzodiazepine-induced and anticholinergic-induced delirium in the elderly. Int Psychogeriatr 1991; 3: 397-408. Go to original source... Go to PubMed...
  27. Cao YJ, Mager DE, Simonsick EM, et al. Physical and cognitive performance and burden of anticholinergics, sedatives, and ACE inhibitors in older women. Clin Pharmacol Ther 2008; 83: 422-429. Go to original source... Go to PubMed...
  28. Cancelli I, Gigli GL, Piani A, et al. Drugs with anticholinergic properties as a risk factor for cognitive impairment in elderly people: a population-based study. J Clin Psychopharmacol 2008; 28: 654-659. Go to original source... Go to PubMed...
  29. Ancelin ML, Artero S, Portet F, Dupuy AM, Touchon J, Ritchie K. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ 2006; 332: 455-459. Go to original source... Go to PubMed...
  30. Defilippi JL, Crismon ML. Drug interactions with cholinesterase inhibitors. Drugs Aging 2003; 20: 437-444. Go to original source... Go to PubMed...
  31. Ahmed S, Chengappa KN, Naidu VR, Baker RW, Parepally H, Schooler NR. Clozapine withdrawal-emergent dystonias and dyskinesias: a case series. J Clin Psychiatry 1998; 59: 472-477. Go to original source... Go to PubMed...
  32. Plevová J, Boleloucký Z. Psychofarmakoterapie vyššího věku. 2. vyd. Praha: Grada Publishing, 2000; 162.
  33. Richelson E. Preclinical pharmacology of neuroleptics: focus on new generation compounds. J Clin Psychiatry 1996; 57(Suppl 11): 4-11.
  34. Vaswani M, Linda FK, Ramesh S. Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27: 85-102. Go to original source... Go to PubMed...
  35. Rudd KM, Raehl CL, Bond CA, Abbruscato TJ, Stenhouse AC. Methods for assessing drug-related anticholinergic activity. Pharmacotherapy 2005; 25: 1592-1601. Go to original source... Go to PubMed...
  36. Tune LE. Serum anticholinergic activity levels and delirium in the elderly. Semin Clin Neuropsychiatry 2000; 5: 149-153. Go to PubMed...
  37. Tune L, Carr S, Hoag E, Cooper T. Anticholinergic effects of drugs commonly prescribed for the elderly: potential means for assessing risk of delirium. Am J Psychiatry 1992; 149: 1393-1394. Go to original source... Go to PubMed...
  38. Han L, Agostini JV, Allore HG. Cumulative anticholinergic exposure is associated with poor memory and executive function in older men. J Am Geriatr Soc 2008; 56: 2203-2210. Go to original source... Go to PubMed...
  39. Rudolph JL, Salow MJ, Angelini MC, McGlinchey RE. The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med 2008; 168: 508-513. Go to original source... Go to PubMed...
  40. Mulsant BH, Pollock BG, Kirshner M, Shen C, Dodge H, Ganguli M. Serum anticholinergic activity in a communitybased sample of older adults: relationship with cognitive performance. Arch Gen Psychiatry 2003; 60: 198-203. Go to original source... Go to PubMed...
  41. Folstein MF, Folstein SE, McHugh PR., ,Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198. Go to original source... Go to PubMed...




Clinical Pharmacology and Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.